A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2001
11/08/2001	CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001	EP1152057A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
11/07/2001	EP1151008A1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
11/07/2001	EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/07/2001	EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001	EP1150991A2 Compositions for treating inflammatory response
11/07/2001	EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
11/07/2001	EP1150978A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
11/07/2001	EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
11/07/2001	EP1150972A1 Triazole and tetrazole derivatives, and their therapeutic use
11/07/2001	EP1150970A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
11/07/2001	EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150954A1 Anti-imflammatory indole derivatives
11/07/2001	EP1150953A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001	EP1150702A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation
11/07/2001	EP1150687A2 Methods for anti-tumor therapy
11/07/2001	EP1150564A1 Inositol derivatives for inhibiting superoxide anion production
11/07/2001	EP0843676B1 Preparations containing ipratropium bromide enantiomer with a prolonged duration of action
11/07/2001	EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same
11/07/2001	EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1321163A Crystal of diuridine tetraphosphate or salt thereof and method for preparing same, and method for producing said compound
11/07/2001	CN1321151A Chemical compounds
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1321149A New crystal modification III of torasemide
11/07/2001	CN1321082A Micronised pharmaceutical compositions
11/07/2001	CN1320603A Process for preparing total alkaloid of siberian fritillary bulb with antitussive and phlegm-eliminating action
11/07/2001	CN1320433A Process for preparing powdered medicine to treat rhinitis and nasosinusitis
11/07/2001	CN1074411C Method for preparing medicinal composition in noval physical form contg. heterocyclic amide deriv.
11/06/2001	US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae
11/06/2001	US6313270 DbpB
11/06/2001	US6313174 Aminobenzophenones as inhibitors of interleukin and TNF
11/06/2001	US6313164 Dithiolin derivatives, their preparation and their therapeutic effect
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313129 Therapeutic compounds
11/06/2001	US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001	US6313116 Phosphodiesterase inhibitors
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/03/2001	CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001	WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001	WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/01/2001	WO2001080891A1 Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
11/01/2001	WO2001080839A2 Use of naphthindazole-4,9-quinones as antiparasitic agents
11/01/2001	WO2001080838A2 Use of n2-substituted benz[f]indazole-4,9-quinones as antiparasitic agents
11/01/2001	WO2001080807A2 Medicine containing polysaccharide substances for activating apoptosis
11/01/2001	WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001	WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001029066A3 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
11/01/2001	WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001	WO2001028570A3 Zinc lactate lozenges and uses thereof
11/01/2001	WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001	US20010036950 Potassium channel openers
11/01/2001	US20010036946 Antiinflammatory agents
11/01/2001	US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001	US20010036927 Complexing
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036898 Activating catalyst; reducing by-products
11/01/2001	US20010036481 Modulation of release from dry powder formulations
11/01/2001	US20010036456 Administering Protein C
11/01/2001	US20010036454 Transfection of lung tissue
11/01/2001	CA2407504A1 Medicine containing polysaccharide substances for activating apoptosis
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2407449A1 Novel compounds
11/01/2001	CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406264A1 Protein phosphatases
11/01/2001	CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
10/2001
10/31/2001	EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001	EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001	EP1149072A1 Sulfonamide hydroxamates
10/31/2001	EP1148905A2 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor

1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 878